EDMONTON, June 28 /CNW/ - Isotechnika Inc. (TSX:ISA) announced today that
the Company will be represented at the 82nd Annual Conference of the Canadian
Dermatology Association. Dr. Norman R Wasel, one of the principal
investigators involved in the Company's Canadian Phase 3 psoriasis trial, will
make an oral presentation titled "Long Term Safety of ISA247 in Plaque
Psoriasis After 60 Weeks of Dosing". The presentation will take place at
10:00 a.m. ET/8:00 a.m. MT on Sunday, July 1st at the Fairmont Royal York
hotel in Toronto, Ontario.
